STABLE PREPARATION OF HUMAN PAPILLOMAVIRUS VIRUS-LIKE PARTICLE VACCINE
Provided is a stable formulation of a human papillomavirus virus-like particle vaccine. The stable formulation is composed of a human papillomavirus virus-like particle, a buffer solution, an osmotic pressure regulator, a surfactant and an aluminum adjuvant, wherein the components of the vaccine comprise HPV virus-like particles assembled by L1 proteins of HPV types 6, 11, 16, 18, 31, 33, 45, 52 and 58, and one or more HPV virus-like particles assembled by L1 proteins of other pathogenic HPV types. The formulation can enhance the stability of the vaccine and prolong the validity period of the vaccine in an aqueous formulation..
Medienart: |
Patent |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Europäisches Patentamt - (2023) vom: 20. Dez. Zur Gesamtaufnahme - year:2023 |
---|
Sprache: |
Englisch |
---|
Beteiligte Personen: |
LIU YAN [VerfasserIn] |
---|
Links: |
Volltext [kostenfrei] |
---|
Themen: |
Sonstige Themen: |
---|
Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2023-12-20, Last update posted on www.tib.eu: 2024-03-19, Last updated: 2024-03-22 |
---|
Patentnummer: |
EP4292607 |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
EPA000957054 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | EPA000957054 | ||
003 | DE-627 | ||
005 | 20240322140716.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240322s2023 xx |||||o 00| ||eng c | ||
035 | |a (DE-627)EPA000957054 | ||
035 | |a (EPA)EP4292607 | ||
035 | |a (EPA)82446926 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 0 | |a LIU YAN |e verfasserin |4 aut | |
245 | 1 | 0 | |a STABLE PREPARATION OF HUMAN PAPILLOMAVIRUS VIRUS-LIKE PARTICLE VACCINE |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Source: www.epo.org (no modifications made), First posted: 2023-12-20, Last update posted on www.tib.eu: 2024-03-19, Last updated: 2024-03-22 | ||
520 | |a Provided is a stable formulation of a human papillomavirus virus-like particle vaccine. The stable formulation is composed of a human papillomavirus virus-like particle, a buffer solution, an osmotic pressure regulator, a surfactant and an aluminum adjuvant, wherein the components of the vaccine comprise HPV virus-like particles assembled by L1 proteins of HPV types 6, 11, 16, 18, 31, 33, 45, 52 and 58, and one or more HPV virus-like particles assembled by L1 proteins of other pathogenic HPV types. The formulation can enhance the stability of the vaccine and prolong the validity period of the vaccine in an aqueous formulation. | ||
650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
650 | 4 | |a che | |
650 | 4 | |a 615 | |
700 | 0 | |a HU PING |4 aut | |
700 | 0 | |a CHANG XINRONG |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2023) vom: 20. Dez. |
773 | 1 | 8 | |g year:2023 |g day:20 |g month:12 |
856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/82446926/publication/EP4292607A1?q=EP4292607 |z kostenfrei |3 Volltext |
912 | |a GBV_EPA | ||
951 | |a AR | ||
952 | |j 2023 |b 20 |c 12 |